anti-Keratin 5 (KRT5) Antibodies

The protein encoded by KRT5 is a member of the keratin gene family. Additionally we are shipping Keratin 5 Kits (15) and Keratin 5 Proteins (15) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
KRT5 110308 Q922U2
KRT5 3852 P13647
KRT5 369017 Q6P6Q2
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-Keratin 5 Antibodies at antibodies-online.com

Showing 10 out of 284 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Human Rabbit Un-conjugated ICC, IF, IHC, IHC (fro), IHC (p), SimWes, WB Simple Western: Cytokeratin 5 Antibody (EP1601Y)  - Simple Western lane view shows a specific band for Cytokeratin 5 in 0.5 mg/ml of A431 lysate. This experiment was performed under reducing conditions using the 12-230 kDa separation system. Immunohistochemistry-Paraffin: Cytokeratin 5 Antibody (EP1601Y)  - Human transitional urinary bladder carcinoma. 0.1 mL Log in to see 7 to 9 Days
$446.35
Details
Cat Mouse Un-conjugated FACS, IHC (fro), IF, IHC (p), WB RCK102 Cytokeratin staining of a human squamous cell carcinoma of the lung. 0.1 mg Log in to see 6 to 8 Days
$434.50
Details
Human Rabbit Un-conjugated IHC (p), WB Cytokeratin 5 was detected in paraffin-embedded sections of human oesophagus squama cancer tissues using rabbit anti- Cytokeratin 5 Antigen Affinity purified polyclonal antibody (Catalog # ) at 1 µg/mL. The immunohistochemical section was developed using SABC method (Catalog # SA1022). Cytokeratin 5 was detected in paraffin-embedded sections of human tonsil tissues using rabbit anti- Cytokeratin 5 Antigen Affinity purified polyclonal antibody (Catalog # ) at 1 µg/mL. The immunohistochemical section was developed using SABC method (Catalog # SA1022). 100 μg Log in to see 4 to 6 Days
$280.00
Details
Human Mouse Un-conjugated CyTOF, ELISA, FACS, ICC, IF, IHC, IHC (p), WB Flow Cytometry: Cytokeratin 5 Antibody (2C2) [NBP2-22194] - Flow cytometric analysis of HeLa cells using Cytokeratin 5 mouse mAb (green) and negative control (red). Immunocytochemistry/Immunofluorescence: Cytokeratin 5 Antibody (2C2) [NBP2-22194] - Immunofluorescence analysis of HeLa cells. Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin. 0.025 mL Log in to see 7 to 9 Days
$162.44
Details
Human Mouse Un-conjugated ELISA, IHC, WB Figure 1: Western blot analysis using CK5 mouse mAb against truncated CK5 recombinant protein Dilution: 1/500 - 1/2000 Figure 2: Immunohistochemical analysis of paraffin-embedded human esophagus epithelium (A), salivary gland basal cell (B), lung squamous cell carcinoma (C), endometrium admosquamous carcinoma (D), showing cytoplasmic and membrane localization using CK5 mouse mAb with DAB staining. Dilution: 1/200 - 1/1000 100 μL Log in to see 10 to 11 Days
$577.50
Details
Cow Rabbit Un-conjugated IC, IF, IHC, WB Immunofluorescent analysis of Cytokeratin 5 staining in HeLa cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with the primary antibody in 3% BSA-PBS and incubated overnight at 4 °C in a humidified chamber. Cells were washed with PBST and incubated with a DyLight 594-conjugated secondary antibody (red) in PBS at room temperature in the dark. DAPI was used to stain the cell nuclei (blue). Immunohistochemical analysis of Cytokeratin 5 staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. 200 μL Log in to see 13 to 14 Days
$487.50
Details
Human Mouse Un-conjugated ELISA, FACS, IHC, WB Black line: Control Antigen (100 ng);Purple line: Antigen(10ng);Blue line: Antigen (50 ng);Red line: Antigen (100 ng); Dilution: 1/10000 Figure 1: Western blot analysis using CK5 mAb against human CK5 recombinant protein. (Expected MW is 47.8 kDa) Dilution: 1/500 - 1/2000 100 μL Log in to see 8 to 11 Days
$577.50
Details
Human Mouse Un-conjugated ELISA, FACS, ICC, IHC, WB Black line: Control Antigen (100 ng);Purple line: Antigen(10ng);Blue line: Antigen (50 ng);Red line: Antigen (100 ng); Dilution: 1/10000 Figure 2:Western blot analysis using CK5 mAb against human CK5 (AA: 258-357) recombinant protein. (Expected MW is 33.1 kDa) Dilution: 1/500 - 1/2000 100 μL Log in to see 8 to 11 Days
$577.50
Details
Human Mouse Un-conjugated ELISA, IHC, WB Black line: Control Antigen (100 ng);Purple line: Antigen(10ng);Blue line: Antigen (50 ng);Red line: Antigen (100 ng); Dilution: 1/10000 Figure 1: Western blot analysis using CK5 mAb against human CK5 recombinant protein. (Expected MW is 47.8 kDa) Dilution: 1/500 - 1/2000 100 μL Log in to see 8 to 11 Days
$577.50
Details
Human Mouse Un-conjugated ELISA, FACS, ICC, IHC, WB Black line: Control Antigen (100 ng);Purple line: Antigen(10ng);Blue line: Antigen (50 ng);Red line: Antigen (100 ng); Dilution: 1/10000 Figure 2:Western blot analysis using CK5 mAb against human CK5 (AA: 258-357) recombinant protein. (Expected MW is 33.1 kDa) Dilution: 1/500 - 1/2000 100 μL Log in to see 8 to 11 Days
$577.50
Details

Top referenced anti-Keratin 5 Antibodies

  1. Human Monoclonal KRT5 Primary Antibody for ICC, IF - ABIN5550532 : Alexander, Reising, Schumacher, Sproll, Stoecklein: Validation of markers for the screening and identification of disseminating tumor cells in lymph nodes and bone marrow. in International journal of clinical pharmacology and therapeutics 2012 (PubMed)
    Show all 6 Pubmed References

  2. Human Monoclonal KRT5 Primary Antibody for ELISA, WB - ABIN969079 : Gu, Kim, Ichiki, Park, Nagai, Kitajima: A usual frameshift and delayed termination codon mutation in keratin 5 causes a novel type of epidermolysis bullosa simplex with migratory circinate erythema. in The Journal of investigative dermatology 2003 (PubMed)
    Show all 3 Pubmed References

  3. Human Monoclonal KRT5 Primary Antibody for IHC, ELISA - ABIN1724790 : Grin, OMalley, Mulligan: Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy. in The American journal of surgical pathology 2009 (PubMed)
    Show all 2 Pubmed References

  4. Human Monoclonal KRT5 Primary Antibody for FACS, IHC - ABIN1724789 : Sugiyama-Fukamatsu, Suzuki, Nakanishi, Iwatsuki: Epidermolysis bullosa nevus arising in a patient with Dowling-Meara type epidermolysis bullosa simplex with a novel K5 mutation. in The Journal of dermatology 2009 (PubMed)
    Show all 2 Pubmed References

  5. Human Monoclonal KRT5 Primary Antibody for IHC, ELISA - ABIN1724880 : Alam, Sehgal, Kundu, Dalal, Vaidya: Novel function of keratins 5 and 14 in proliferation and differentiation of stratified epithelial cells. in Molecular biology of the cell 2011 (PubMed)
    Show all 2 Pubmed References

  6. Human Monoclonal KRT5 Primary Antibody for IHC, ELISA - ABIN969078 : Canedo-Patzi, León-Bojorge, de Ortíz-Hidalgo: [Adenomatoid tumor of the genital tract. Clinical, pathological and immunohistochemical study in 9 cases]. in Gaceta médica de México 2006 (PubMed)
    Show all 2 Pubmed References

  7. Human Monoclonal KRT5 Primary Antibody for IHC, ELISA - ABIN965962 : Nishizawa, Izawa, Inoko, Hayashi, Nagata, Yokoyama, Usukura, Inagaki: Identification of trichoplein, a novel keratin filament-binding protein. in Journal of cell science 2005 (PubMed)
    Show all 2 Pubmed References

  8. Cow (Bovine) Polyclonal KRT5 Primary Antibody for IHC (fro), IHC (p) - ABIN113452 : Huijbregts, Bots, Wittens, Schrama, Moll, Blankestijn,: Hemodialysis Arteriovenous Fistula Patency Revisited: Results of a Prospective, Multicenter Initiative. in Clinical journal of the American Society of Nephrology : CJASN 2008 (PubMed)
    Show all 2 Pubmed References

More Antibodies against Keratin 5 Interaction Partners

Mouse (Murine) Keratin 5 (KRT5) interaction partners

  1. We demonstrate using lineage-tracing systems that urothelial regeneration following augmentation cystoplasty with acellular grafts exclusively depends on host keratin 5-expressing basal cells to repopulate all lineages of the de novo urothelium at implant sites

  2. CDK1, Aurora-B, and Rho-kinase phosphorylate keratin 5/14.

  3. Taken together, our data demonstrated that Krt5-expressing cells could be involved in the natural pancreas self-healing process and the renewal of beta cells after AP in adult mice. It is promising that promoting conversion of Krt5-expressing cells into functional beta cells may be a novel method to mitigate the development of diabetes mellitus after AP in vivo.

  4. RA regulates Krt5 and Krt14 expression independently of stem cell character in developing salivary epithelium. The stem cell gene Kit is regulated inversely from Krt5/Krt14 by RA signaling.

  5. widespread destruction of airway and alveolar epithelial cells following severe influenza infection triggers a wound-healing response that initiates in the airways with the proliferation of rare airway-resident SOX2+ Lin- progenitor cells. These cells then give rise to nascent KRT5+ cells in remodeled airways and populate the damaged alveolar parenchyma.

  6. Loss of activating transcription factor 3 (ATF3) in knockout mice promotes the emergence of keratins CK5+CK8+ epithelial cells.

  7. B-1 B cells transiently and partially express K5 in bone marrow and are potent for both natural antibody production and antigen presentation.

  8. Directed expression of a chimeric type II keratin partially rescues keratin 5-null mice.

  9. NMHC IIA may play critical roles in the early trophoblast-derived ectoplacental cone and extraembryonic ectoderm in Keratin 5-Cre transgenic mice.

  10. Mice lacking the prostate epithelial AR have increased apoptosis in epithelial CK8-positive luminal cells and increased proliferation in epithelial CK5-positive basal cells.

  11. The involvement of Hsc70 and Hsp70 in mutant keratin degradation was demonstrated using CHIP-p.Met1_Ala142del (DeltaTPR-CHIP).

  12. p63 protein is essential for the embryonic development of vibrissae and teeth; while it localizes with K5 in vibrissae, it is not fully colocalized with nuclear Ki67 expression

  13. keratin 5 mutations contribute to epidermolysis bullosa simplex in a mouse model by inducing local inflammation that mediates a stress response

  14. Cytokines involved in the recruitment, maturation, and migration of Langerhans cells in the epidermis, are upregulated in the skin of K5(-/-) and epidermolysis bullosa simplex patients.

  15. DeltaNp63 alone can restore the expression of the basal keratins and reinitiate the failed epidermal differentiation program in the skin of p63 null animals.

Human Keratin 5 (KRT5) interaction partners

  1. A description of the Epidermolysis bullosa simplex phenotype in patients with an identical heterozygous p.Glu477Lys mutation in keratin 5.

  2. combination of KRT5 and KRT20 allowed identification of patients with a very poor prognosis (KRT20/KRT5(-), 5-year DSS 0%, p < 0.0001). In silico analysis of the independent MDACC cohorts revealed congruent results (5-year DSS for KRT20 low vs. high: 84% vs. 40%, p = 0.042).

  3. Cytokeratin 5/6 and CK8/18 immunohistochemistry on 150 cases of triple negative breast cancers was performed and association with various clinicopathological features was evaluated.

  4. Data indicate that cytokeratin 5/6 (CK5/6) is an independent prognostic biomarker in urothelial carcinoma and therefore can be used in the prognostic stratification of the patients with bladder cancer.

  5. CK5/6 expression changed according to the morphological components in adenoid cystic carcinoma of the breast.

  6. EGFR and CK5/6 expression could serve as biomarkers for identifying triple-negative breast cancer patients with poor survival

  7. Basal cell carcinoma (BCC) typically shows patchy CD56 expression and diffuse CK5/6 positivity. These 2 markers can be used to distinguish between BCC and Merkel cell carcinoma in challenging cases.

  8. Negative staining for CK5/6 and p63 can be helpful to distinguish Well-differentiated neuroendocrine tumors (WDNETs) from cutaneous adnexal neoplasms. It is important to consider WDNETs in the differential diagnosis of cutaneous adnexal neoplasms as low-grade tumors may be the first sign of aggressive metastatic disease

  9. this study adds a further 10 novel mutations to the catalogued genotype-phenotype correlations in epidermolysis bullosa simplex and demonstrates a potential modifying effect of SNPs on the phenotype. We therefore support the notion of full DNA sequencing of both KRT5 and KRT14 genes so as to not miss any variants in the genes contributing to the phenotype.

  10. Flat Intraurothelial Neoplasia Exhibiting Diffuse Immunoreactivity for CD44 and Cytokeratin 5 (Urothelial Stem Cell/Basal Cell Markers): A Variant of Intraurothelial Neoplasia Commonly Associated With Muscle-invasive Urothelial Carcinoma

  11. Dual small interfering RNA (siRNA) silencing of RARalpha and RARgamma reversed RA blockade of P4-induced CK5. Using promoter deletion analysis, we identified a region 1.1 kb upstream of the CK5 transcriptional start site that is necessary for P4 activation and contains a putative progesterone response element (PRE

  12. Cytokeratin 5/6 protein expression as a frequent feature of high-grade serous ovarian carcinoma with various staining patterns. Cytokeratin 5/6 in combination with ER-alpha proved to be a negative prognostic marker.

  13. The proportion of serous ovarian carcinomas with high K5/6 or high K5 immunostaining was significantly increased following neoadjuvant chemotherapy. K5 can be used to predict serous ovarian cancer prognosis and identify cancer cells that are resistant to chemotherapy.

  14. CK5 and p40 are good diagnostic markers for squamous cell carcinoma and superior to p63

  15. The expression of CK5/6 and of P63 suggests a squamous differentiation including in the basaloid thyroid lymphoepithelial complexes

  16. Immunocytochemistry using this antibody cocktail comprises five antibodies recognising p63, and cytokeratins ( 7, 18, 5 and 14) showed good sensitivity and specificity for diagnosing breast cancers. Thus, this method is useful for mammary cytology using FNA

  17. the consistency test results indicated the inter-observer agreement was more robust in MS images for HER2 , CK5/6 and ER than that in RGB images for HER2 , CK5/6 and ER .

  18. the luminal cells of adenoid cystic carcinoma show a unique aberrant staining pattern for cytokeratin 5/6 that may aid in the differential diagnosis

  19. Results provide further accumulation of case series of EBS-MP and DPR may provide more accurate diagnostic criteria for genetic disorders of the K5/K14 pair, previously believed to be independent disorders.

  20. The results introduce a case of special generalized DDD with a family history that clinically resembles dyschromatosis universalis hereditaria (DUH), and suggest that KRT5 may be the candidate gene.

Cow (Bovine) Keratin 5 (KRT5) interaction partners

  1. NMHC IIA may play critical roles in the early trophoblast-derived ectoplacental cone and extraembryonic ectoderm in Keratin 5-Cre transgenic mice.

  2. G to A substitution in all affected animals. This mutation leads to an amino acid change of glutamic acid to lysine in the final E (478) of the KLLEGE motif of the protein.

Zebrafish Keratin 5 (KRT5) interaction partners

  1. data show that a cis-element of the DNA segment in the CKII gene is required for epidermal cell-specific expression of CKII and that a minimal region upstream of the transcription start site is required for this expression restricted to epidermal cells

Keratin 5 (KRT5) Antigen Profile

Protein Summary

The protein encoded by this gene is a member of the keratin gene family. The type II cytokeratins consist of basic or neutral proteins which are arranged in pairs of heterotypic keratin chains coexpressed during differentiation of simple and stratified epithelial tissues. This type II cytokeratin is specifically expressed in the basal layer of the epidermis with family member KRT14. Mutations in these genes have been associated with a complex of diseases termed epidermolysis bullosa simplex. The type II cytokeratins are clustered in a region of chromosome 12q12-q13.

Gene names and symbols associated with anti-Keratin 5 (KRT5) Antibodies

  • keratin 5 (Krt5) antibody
  • keratin 5 (KRT5) antibody
  • keratin 5 (krt5) antibody
  • 3300001P10Rik antibody
  • AW146334 antibody
  • CK-5 antibody
  • CK5 antibody
  • ckii antibody
  • DDD antibody
  • DDD1 antibody
  • EBS2 antibody
  • K5 antibody
  • Keratin-5 antibody
  • Krt2-5 antibody
  • KRT5A antibody
  • KRT75 antibody
  • Sak57 antibody
  • Tfip8 antibody
  • wu:fb02h09 antibody
  • wu:fj02d02 antibody
  • wu:fk78b12 antibody
  • zfCKII antibody

Protein level used designations for anti-Keratin 5 (KRT5) Antibodies

58 kDa cytokeratin , CK-5 , cytokeratin 5 , cytokeratin-5 , keratin complex 2, basic, gene 5 , keratin, type II cytoskeletal 5 , keratin-5 , tuftelin interacting protein 8 , type-II keratin Kb5 , 58 kda cytokeratin , epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types , keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types) , K5 , keratin, type II cytoskeletal 60 kDa, component III , keratin 5 (epidermolysis bullosa simplex Dowling-Meara/Kobner/Weber-Cockayne types) , type II cytokeratin , keratin 75 , type II alpha keratin IIA , Cytokeratin-5 , Type-II keratin Kb5

GENE ID SPECIES
110308 Mus musculus
3852 Homo sapiens
281268 Bos taurus
369017 Rattus norvegicus
797351 Danio rerio
407779 Gallus gallus
100615215 Pan troglodytes
100687760 Canis lupus familiaris
100511564 Sus scrofa
Selected quality suppliers for anti-Keratin 5 (KRT5) Antibodies
Did you look for something else?